Navigation Links
Some patients may not need insulin for long-term control of type 2 diabetes
Date:6/15/2008

Some patients with type 2 diabetes can control their disease for years yet avoid insulin injections by using multiple classes of oral diabetic medications, a new study found. The results were presented Sunday, June 15, at The Endocrine Society's 90th Annual Meeting in San Francisco.

Findings from the study contradict common beliefs about non-insulin diabetic medications, said principal investigator Arthur Swislocki, MD, of the Veterans Affairs (VA) Northern California Health Care System in Martinez. Oral diabetes medications help control blood glucose, or sugar, levels in people whose bodies still produce some insulin, as is true for many patients with type 2 diabetes.

"Generally, both patients and physicians believe that long-term use of oral diabetic medications is not possible because these drugs lose their effectiveness over time as the patient's pancreas fails," Swislocki said. "Our data suggest that some patients can remain in good glucose control for years using non-insulin, oral diabetic agents."

The study result is good news for people who need medical therapy for type 2 diabetes, according to Swislocki. "They may be able to delay or avoid the use of insulin," he said.

Some patients prefer pills over insulin injections because they are easier to use or because the patient fears needles or getting low blood sugar, as is possible with insulin treatment, he said.

Swislocki and his coworkers studied the VA medical records of 191 veterans (188 men and 3 women) with type 2 diabetes who received treatment beginning in 1992 and received follow-up for 15 consecutive years. Of these patients, 96 began treatment solely with oral drugs. The researchers found that 55 percent of the patients (53 of 96) who started treatment with oral diabetic agents were able to continue using them 15 years later and achieve good blood sugar control. A measure of long-term blood sugar controlhemoglobin A1cimproved from an average of nea
'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Nurses, Doctors, Patients to Protest Health Insurers at National Day of Action - June 19th
2. Joint distraction promotes structural repair in patients with severe knee osteoarthritis
3. 30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
4. Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patients
5. Serum sodium predicts mortality 10 times higher in PAH patients
6. Syntermed licenses Emory imaging technology for improved evaluation of heart failure patients
7. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
8. Research shows patients must re-learn going from sitting to standing after total knee replacement
9. New self-management program offers significant benefits for arthritis patients with chronic pain
10. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
11. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Research Triangle Dental (RTDental),...Carolina, today announced the expansion of its ser... Dentist, Dr. Doug Macmillan. , ...Dental is pleased to announce that Dr. Doug Macmil...completed an additional advanced training seminar....
(Date:11/25/2009)...ASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConven...edicalcliniconDec.9-10,whenKansasCityhoststhelates...,, "Thisfreecliniceventhasthepotentialtobethebi...fjustoneandbeheldonweekdaysinsteadofoveraweekend,"...thClinicandpresidentoftheNationalAssociationofFree...
(Date:11/25/2009)...BEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmeals...sinthegreaterLongBeachareathankstoFaithInAction/Vo...ceatHome(IAH),adivisionofSCANHealthPlan.Formoretha...lunteerstodeliverwarmThanksgivingmealstoseniorsinn...osAngelesandsurroundingcities. ,, "Ourwarmholid...
(Date:11/25/2009)...adPoliticalEndorsements,Business,andPressJoinEffor...USNewswire/--Onceagain,theNationalBipolarFoundatio...orsingtheir"Safe,tilStable"program,whichisnowbeing...olardisorder.Today,theNationalBipolarFoundationrec...iorityMailfromtheLt.GovernorofLouisianaMitchLandri...
(Date:11/25/2009)...s increase blood pressure? This simple question h...rs. New Stress-related gene Modulates High Blood ...d pressure? This simple question has been the foc...search has for the first time established a link b...sure response to stress in mice as well as humans....
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
... In Total Revenue To $4.7 Million, IDAHO FALLS, I...ulletin Board: INIS) announces the financial resul...l revenue in 2007 was $4,690,588 compared to $4,46...balt,product revenue in 2007 compared to 2006 that...
...19.4 percent -- Annual revenues inc...p 7.4 percent for 2007, LANSING, Mich., March 28 ... provider FinCor Holdings Inc. reported its,quarte... The Company posted a 7.4 percent increase in net ...
...stralias most esteemed scientists is Professor Pat...tute, (CMRI) who has just been elected as a Fellow...herty, Ian Frazer and Fiona Stanley are also among...m and his team have recently completed a fate map ...
...Giving Back Through Fitness Fundraiser for St. ..., FORT LAUDERDALE, Fla., March 28 Four thousand ...hey crunch their abs for one,hour straight during ...ms will host the fitness challenge, with a,goal to...
... Christine A. Mundkur, Esq. ... Barr Laboratories, Inc., -...onsibility for Barr,s global generics business...hip, Barr Laboratories will continue to suppor...
...n (seafood) omega-3,polyunsaturated fatty acids (P... and eye health, according to recent research summ...sletter electronic publications.,Groundbreaking st...ticity, which allows,for more rapid blood flow, wa...
Other Medicine News:Health News:International Isotopes Inc. Announces Year End Financial Results 2Health News:International Isotopes Inc. Announces Year End Financial Results 3Health News:International Isotopes Inc. Announces Year End Financial Results 4Health News:International Isotopes Inc. Announces Year End Financial Results 5Health News:International Isotopes Inc. Announces Year End Financial Results 6Health News:FinCor Holdings Posts Strong Fourth Quarter and Year-End Results 2Health News:FinCor Holdings Posts Strong Fourth Quarter and Year-End Results 3Health News:National recognition for top scientist 2Health News:4,000 Women Attempt New World Record at 2008 Lady of America/Ladies Workout Express Ab Crunch Challenge 2Health News:Barr Pharmaceuticals, Inc. Executive Bios 2Health News:Barr Pharmaceuticals, Inc. Executive Bios 3Health News:Barr Pharmaceuticals, Inc. Executive Bios 4Health News:Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes 2
(Date:11/25/2009)...alif.,Nov.25/PRNewswire/--PraxisElectronicMedicalR...myofFamilyPhysicians,(AAFP)FamilyPracticeManagemen...icalquality,healthmaintenance,anddiseasemanagement...soranked#1amongdoctorsindicatingtheirEMRhadapositi...orankednumberoneinthecountryinprovidingexcellenttr...
(Date:11/25/2009)...J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(N...ommittedtodiscovering,developingandcommercializing...resultsforthefiscalyearendedSeptember30,2009.AtSep...equivalentsandshortterminvestments. ,, Pipelin...hase2bTrial ,, InlateNovember2009,anindepende...
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditionala...nucleosidereversetranscriptaseinhibitor(NNRTI).INT...reatment-experiencedadultswhoareexperiencingvirolo...erantiretroviral(ARV)agents.Thetraditionalapproval...T-1andDUET-2.INTELENCEiscurrentlymarketedintheU.S....
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Vein Condition May Mask Serious Clot Disorder 52152 1Vein Condition May Mask Serious Clot Disorder 52152 2High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 1High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 2High Salt Diet Dampens Effects of Blood Pressure Drugs 52147 3PFCD Urges Congress to Address Real Cost Driver in Health Reform in Light of New CBO Statement 52143 1PFCD Urges Congress to Address Real Cost Driver in Health Reform in Light of New CBO Statement 52143 2
...stria, Sept. 5 Four analyses of three-year,follow...ng Coronary Stent,may be considered an appropriate...ockages in two or more coronary arteries (multives...k at the European Society of Cardiology,Congress 2...sought to assess the long-term impact of the,CYPHE...
...cal and Phase 1 Data Scheduled for Presentation at...-19, 2007 -, CARLSBAD, Calif., Sept. 4 Ardea Bio...that it has successfully completed,Phase 1 single-...ct, and,drug-interaction studies of RDEA806, a nov...tor (NNRTI), in healthy volunteers. The data from...
Other Medicine Technology:Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 2Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 3Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 4Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
Phosohorus (Inorganic) Liquid
Bilirubin (Liquid)
Anti-Streptolysin O (ASO)
Urinary Protein (Liquid)
Medicine Products: